Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Neuropathic Pain

In brief

Based on laboratory studies, donepezil will improve pain relief more than placebo in patients with chronic neuropathic pain who are currently taking gabapentin or pregabalin.

Key facts

Study ID
NCT01743976
Run by
Wake Forest University
People needed
5
Starts
2012-12-01
Expected to finish
2013-10-23
Last updated by the study team
2021-03-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.